Congo's Ebola outbreak kills more than 3,000, government figures show

FILE PHOTO: Displaced people watch a health worker in full personal protective equipment (PPE) preparing to disinfect the area during the burial of suspected Ebola victims at the Kigonze displaced persons camp in Bunia, eastern Democratic Republic of Congo, on June 18, 2026, one month after the outbreak was declared.

FILE PHOTO: Displaced people watch a health worker in full personal protective equipment (PPE) preparing to disinfect the area during the burial of suspected Ebola victims at the Kigonze displaced persons camp in Bunia, eastern Democratic Republic of Congo, on June 18, 2026, one month after the outbreak was declared. (REUTERS/Gradel Muyisa Mumbere/File Photo)


1 photo
Save Story

Estimated read time: 1-2 minutes

DAKAR, Sept 2 — The number of deaths in Democratic Republic of Congo's Ebola ​outbreak has surpassed 3,000, government data showed on Wednesday, as the country's worst-ever epidemic continues to spread across its ‌northeast.

The outbreak, caused by the Bundibugyo species of Ebola, became the largest and ⁠deadliest in Congo's history after ​surpassing the 2018-2020 epidemic.

It is ⁠now second only to the 2014-2016 West African outbreak, which ‌infected over 28,600 ‌people and killed more than 11,000 across Guinea, Liberia and ⁠Sierra Leone.

Government figures showed the ⁠death toll had risen to 3,007, while confirmed cases reached 6,186.

The outbreak was formally declared in Ituri province on May 15, though some health officials and experts say it may have started as early as January.

It has since spread ‌to six provinces, despite efforts by ​Congolese authorities, the World Health Organisation and aid groups to contain it.

Health experts say weak surveillance systems, insecurity and community resistance have hampered efforts to identify and treat patients early.

The World Health Organisation estimates that around 60% of deaths happen outside treatment centres, highlighting the challenges of detecting cases ​before patients succumb to the disease.

Bundibugyo has no approved vaccines or ‌treatments, but several ‌vaccines are ⁠under development, including candidates from the University of Oxford and the International AIDS Vaccine Initiative (IAVI).

Congolese authorities recently began vaccinating frontline health workers with Merck's Ervebo vaccine, which is licensed against the ‌Zaire species of Ebola, ​and is believed to offer some ‌cross-protection against Bundibugyo.

(Reporting by ⁠Clement Bonnerot; ​Additional reporting and writing by Nilutpal Timsina; Editing by Robbie Corey-Boulet, ​Alexandra Hudson)

Photos

Most recent Lifestyle stories

Related topics

Reuters
    KSL.com Beyond Business
    KSL.com Beyond Series

    KSL Weather Forecast

    KSL Weather Forecast
    Play button